1. Home
  2. ASTH vs NKTR Comparison

ASTH vs NKTR Comparison

Compare ASTH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$33.92

Market Cap

1.9B

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$68.62

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
NKTR
Founded
1994
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
ASTH
NKTR
Price
$33.92
$68.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$34.86
$146.67
AVG Volume (30 Days)
287.8K
531.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$519,907,752.00
$307,711,000.00
Revenue This Year
$27.38
N/A
Revenue Next Year
$10.78
N/A
P/E Ratio
$49.49
N/A
Revenue Growth
45.90
86.00
52 Week Low
$18.08
$33.40
52 Week High
$51.60
$109.00

Technical Indicators

Market Signals
Indicator
ASTH
NKTR
Relative Strength Index (RSI) 31.55 42.22
Support Level $20.57 $64.99
Resistance Level $40.11 $76.63
Average True Range (ATR) 1.74 2.76
MACD -0.39 -0.61
Stochastic Oscillator 8.37 21.41

Price Performance

Historical Comparison
ASTH
NKTR

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: